VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 106 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,508 | -32.3% | 1,743 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $19,957 | -79.3% | 1,743 | -80.7% | 0.00% | -50.0% |
| Q3 2020 | $96,542 | -15.5% | 9,048 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $114,186 | +37.9% | 9,048 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $82,789 | -34.4% | 9,048 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $126,220 | -18.9% | 9,048 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $155,716 | -36.8% | 9,048 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $246,287 | +42.2% | 9,048 | 0.0% | 0.00% | +33.3% |
| Q1 2019 | $173,179 | +103.6% | 9,048 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $85,051 | -50.3% | 9,048 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $171,188 | -99.9% | 9,048 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $176,798,000 | +59.7% | 9,048 | +53.6% | 0.00% | +50.0% |
| Q1 2018 | $110,692,000 | +112851.0% | 5,891 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $98,000 | -57.0% | 5,891 | -46.8% | 0.00% | 0.0% |
| Q3 2017 | $228,000 | – | 11,083 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 7,891,176 | $154,194,000 | 51.35% |
| Trustees of Princeton University | 203,638 | $3,979,000 | 4.13% |
| Casdin Capital, LLC | 1,135,000 | $22,178,000 | 3.10% |
| GREAT POINT PARTNERS LLC | 730,010 | $14,264,000 | 1.98% |
| BB BIOTECH AG | 2,532,641 | $49,488,000 | 1.43% |
| Aevitas Wealth Management, Inc. | 73,323 | $1,433,000 | 1.40% |
| Patriot Financial Group Insurance Agency, LLC | 64,256 | $1,256,000 | 1.34% |
| Virtus ETF Advisers LLC | 37,502 | $733,000 | 0.65% |
| Eventide Asset Management | 703,425 | $13,745,000 | 0.57% |
| THOMPSON DAVIS & CO., INC. | 11,951 | $234,000 | 0.56% |